Unexplained loss of consciousness: Systemic mastocytosis

Journal of the Royal Society of Medicine

Volumn 93, Issue 3, 2000, Pages 141-142

  Valabhji, Jonathan ^a   Robinson, Stephen ^a   Johnston, Desmond ^a   Bellamy, Michael ^a   Davies, Wyn ^a   Bain, Barbara J ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE;

ADULT; ARTICLE; CASE REPORT; CONSCIOUSNESS; DIET THERAPY; HUMAN; HYPERTENSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SYSTEMIC MASTOCYTOSIS;

EID: 0034073664     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1177/014107680009300309     Document Type: Article

References (7)

1. 1 Bain B. Systemic mastocytosis and other mast cell neoplasms. Br J Haematol 1999;106:9-17
2. 2 Travis W, Li C-Y, Bergstralh E, Yam L, Swee R. Systemic mast cell disease: analysis of 58 cases and literature review. Medicine 1988;67:345-68
3. 3 Dodd N, Bond M. Fatal anaphylaxis in systemic mastocytosis. J Clin Pathol 1979;32:31-4
4. 4 Golkan I, Nernhard J. Mastocytosis. Lancet 1997;349:1379-85
5. 5 Frieri M, Alling D, Metcalfe D. Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis: results of a double-blind clinical trial. Am J Med 1985;78:9-14
6. 6 Hubner C, Wedding U, Strater J, Limburg B, Stremmel W. Clinically stable systemic mastocytosis with interferon alpha-2b therapy. J Intern Med 1997;241:529-33
7. 7 Pignon J-M, Giraudier S, Duquesnoy P, et al. A new c-kit mutation in a case of aggressive mast cell disease. Br J Haematol 1997;96:374-6